Elixirgen Therapeutics is a clinical-stage biotech company focused on the discovery and development of innovative therapies, including cell and gene therapies. The Company is advancing three technologies to develop therapeutics for a broad spectrum of diseases including rare and genetic diseases, and aging-related disorders. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.
| Website | https://elixirgentx.com/ |
| Employees | 13 (7 on RocketReach) |
| Founded | 2017 |
| Phone | +1 443-451-5300 |
| Technologies |
HTML
,
Twitter
,
Google Analytics
+8 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering, Pharmaceuticals |
| Keywords | Rna Therapeutics, Gene Therapy, Cell Therapy, Clinical Stage, Drug Discovery, Biotechnology, Pharmaceutical, Therapeutics, Molecular Medicine, Innovative Therapies, Rna Technology, Genetic Medicine, Clinical Development, Drug Development, Biopharma, Life Sciences, Precision Medicine, Regenerative Medicine, New Therapies, Healthcare |
| Competitors | Moderna Therapeutics, CureVac, Zymergen, Inc., Genentech, Regeneron, Novavax, Zymeworks Inc., Sutro Biopharma, Inc., Amgen, AstraZeneca +40 more (view full list) |
Looking for a particular Elixirgen Therapeutics, Inc. employee's phone or email?
Aki Ko is the CEO of Elixirgen Therapeutics, Inc..
7 people are employed at Elixirgen Therapeutics, Inc..
Elixirgen Therapeutics, Inc. is based in Baltimore, Maryland.